NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE196182 Query DataSets for GSE196182
Status Public on Feb 09, 2022
Title Interleukin-10 contributes to reservoir establishment and persistence in antiretroviral therapy-treated, SIV-infected macaques
Organism Macaca mulatta
Experiment type Expression profiling by high throughput sequencing
Summary Interleukin (IL)-10 is an immunosuppressive cytokine that signals through STAT3 to regulate T follicular helper cell (TFH) differentiation and germinal center formation. In SIV-infected macaques, levels of IL-10 in plasma and lymph node (LN) are induced by infection and not normalized with ART. During chronic infection, plasma IL-10 and transcriptomic signatures of IL-10 signaling were significantly correlated with the cell-associated SIV-DNA content within LN CD4+ memory subsets, including TFH, and predicted the frequency of CD4+ TFH and their cell- associated SIV-DNA content during ART, respectively. Notably, in ART-treated RMs, cells harboring SIV-DNA by DNAscope were preferentially found in the LN B-cell follicle in close proximity to IL-10. Finally, we demonstrate that the in vivo neutralization of soluble IL-10 in ART-treated, SIV-infected macaques significantly reduces B cell follicle maintenance and, by extension, cellular sites of viral persistence, including LN TFH and memory CD4+ T-cells expressing PD-1 and CTLA-4. Thus, these data support a role for IL-10 in maintaining a pool of target cells in lymphoid tissue that serve as a niche for viral persistence. Targeting IL-10 signaling to impair CD4+ T-cell survival and improve antiviral immune responses may represent a novel approach to limit viral persistence in ART-suppressed people living with HIV.
 
Overall design 16 female Indian-origin, specific-pathogen-free (SPF) rhesus macaques were infected with SIVmac239 and at day 60 post-infection (p.i.) began a 5-drug, oral antiretroviral therapy. Starting at d60 and d203 p.i., seven RMs began 6-dose, weekly cycle of subcutaneous rhesus IL-21-IgFc (IL-21)
 
Contributor(s) Harper J, Ribeiro SP, Chan CN, Aid M, Deleage C, Micci L, Pino M, Cervasi B, Raghunathan G, Rimmer E, Ayanoglu G, Wu G, Shenvi N, Barnard RJ, Prete GD, Busman-Sahay K, Bosinger S, Easley K, Howell BJ, Gorman D, Hazuda DJ, Estes JD, Sekaly R, Paiardini M, Tharp GK
Citation(s) 35230978
Submission date Feb 04, 2022
Last update date Aug 07, 2023
Contact name Gregory K Tharp
E-mail(s) gktharp@emory.edu
Phone 404-727-7797
Organization name Yerkes National Primate Research Center
Department Developmental and Cognitive Neuroscience
Lab Genomics Core
Street address 954 Gatewood Dr
City Atlanta
State/province GA
ZIP/Postal code 30329-4208
Country USA
 
Platforms (2)
GPL20313 Illumina HiSeq 1000 (Macaca mulatta)
GPL23804 Illumina HiSeq 3000 (Macaca mulatta)
Samples (59)
GSM5862165 RLm12_Pre-Infection
GSM5862166 ROe12_Pre-Infection
GSM5862167 RBt12_Pre-Infection
Relations
BioProject PRJNA803542

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE196182_Raw_Read_Counts_Justin-2020-07-14.txt.gz 1.4 Mb (ftp)(http) TXT
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap